USAQ (QHSLab) Tax Provision : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 1990. Start your Free Trial

What is QHSLab Tax Provision?

QHSLab's tax provision for the three months ended in Sep. 2024 was $0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

QHSLab Tax Provision Historical Data

The historical data trend for QHSLab's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Tax Provision Chart

QHSLab Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

QHSLab Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-	-	-	-	-

QHSLab Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

QHSLab Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407

Website

https://www.qhslab.com

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Executives

Troy James Grogan	director, 10 percent owner, officer: CEO/Director	5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin	director, 10 percent owner, officer: CEO & Chairman	90 JOHN STREET, SUITE 626, NEW YORK NY 10038